1. Adipokine receptor expression in mast cells is altered by specific ligands and proinflammatory cytokines.
- Author
-
Żelechowska P, Wiktorska M, Kozłowska E, and Agier J
- Subjects
- Animals, Rats, Ligands, Male, Receptors, Chemokine metabolism, Chemokines metabolism, Adiponectin metabolism, Receptors, Adiponectin metabolism, Receptors, Leptin metabolism, Inflammation immunology, Inflammation metabolism, Intercellular Signaling Peptides and Proteins metabolism, Receptors, Adipokine metabolism, Signal Transduction, Inflammation Mediators metabolism, Adipokines metabolism, Cells, Cultured, Mast Cells metabolism, Mast Cells immunology, Cytokines metabolism, Leptin metabolism
- Abstract
Adipokines play essential roles in regulating a range of biological processes, but growing evidence indicates that they are also fundamental in immunological mechanisms and, primarily, inflammatory responses. Adipokines mediate their actions through specific receptors. However, although adipokine receptors are widely distributed in many cell and tissue types, limited data are available on their expression in mast cells (MCs) and, consequently, adipokine's significance in the modulation of MC activity within the tissues. In this study, we demonstrate that rat peritoneal MCs constitutively express the leptin receptor (i.e. LEPR), adiponectin receptors (i.e. ADIPOR1 and ADIPOR2) and the chemerin receptor (i.e. CMKLR1). We also found that LEPR, ADIPOR1, ADIPOR2 and CMKLR1 expression in MCs changes in response to stimulation by their specific ligands and some cytokines with potent proinflammatory properties. Furthermore, the involvement of intracellular signaling molecules in leptin-, adiponectin- and chemerin-induced MC response was analyzed. Overall, our findings suggest that adipokines leptin, adiponectin and chemerin can significantly affect the activity of MCs in various processes, especially during inflammation. These observations may contribute significantly to understanding the relationship between adipokines, immune mechanisms and diseases or conditions with an inflammatory component., (© 2024 the Australian and New Zealand Society for Immunology, Inc.)
- Published
- 2024
- Full Text
- View/download PDF